<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To study the effects of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> transporters on the pathogenesis of brain <z:mpath ids='MPATH_124'>infarct</z:mpath>, pharmacological and histological analyses were carried out on the thrombotic focal ischemic model </plain></SENT>
<SENT sid="1" pm="."><plain>Expression of <z:chebi fb="2" ids="33699">mRNA</z:chebi> coding for the <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> transporter GLAST increased significantly in the penumbra at 72 h following the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Combined with confocal laser scanning microscopic analysis, double staining showed expression of GLAST <z:chebi fb="2" ids="33699">mRNA</z:chebi> in both neurons and glial cells in the penumbra </plain></SENT>
<SENT sid="3" pm="."><plain>L-trans-<z:chebi fb="0" ids="33135">Pyrrolidine</z:chebi>-2,4-<z:chebi fb="0" ids="28965">dicarboxylate</z:chebi> (L-trans-PDC), a <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> uptake inhibitor, dose-dependently enhanced the volume of the <z:mpath ids='MPATH_124'>infarct</z:mpath> induced by the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The results suggest that a compensatory increase in the activity of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> transporter may accompany pathological changes after ischemic injury </plain></SENT>
</text></document>